Alex Parker

Alex Parker is an experienced professional in the biotechnology and life sciences sectors, currently serving as a Strategic Advisor at Tracer Biotechnologies and Mursla Bio, while also holding multiple leadership roles, including Board Member at Paige and member of the Board of Directors at Genome Medical, Precede Biosciences, and Franklin Land Trust. With a strong background in molecular genetics, evidenced by a PhD from the University of Maine, and a dual degree in Philosophy and Biology from The University of New Mexico, Alex has been actively involved in various organizations such as Universal Diagnostics S.A., Casdin Capital, LLC, Earli Inc., and Exai Bio since 2021.